MRI for Throat Cancer

(OPSCC Trial)

LD
MS
Overseen ByMarisa Sanchez, Bachelor of Science
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Abramson Cancer Center at Penn Medicine
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The purpose of this research study is to investigate the relationship between vascular habitats and treatment response AND to investigate the potential utility of dynamic contrast enhanced (DCE)-MRI derived parameters in predicting treatment response.

This data can be used to assist in the development of a clinical decision support (CDS) tool for risk categorization and individualized decision-making. While "low-risk" patients could benefit from de-escalated radiation therapy, "high-risk" patients could receive early initiation of targeted therapies, or immunotherapies.

Who Is on the Research Team?

SC

Sanjeev Chawla

Principal Investigator

University of Pennsylvania

Are You a Good Fit for This Trial?

This study is for people diagnosed with HPV-positive throat cancer (specifically oropharyngeal squamous cell carcinoma).

Inclusion Criteria

I am 18 years old or older.
I have a biopsy-confirmed diagnosis of oropharyngeal cancer.
Willingness to undergo multiple phlebotomy during standard CRT for liquid biopsy analyses
See 3 more

Exclusion Criteria

My cancer has spread to distant parts of my body.
My oropharyngeal cancer is HPV-negative.
I have significant bleeding near my tumor that may affect scan quality.
See 4 more

What Are the Treatments Tested in This Trial?

Trial Overview

Researchers are using a special MRI scan called DCE-MRI to see if certain imaging features can predict how well patients respond to treatment. The goal is to help guide future personalized treatment plans.

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: HPV Positive Oropharyngeal Squamous Cell CarcinomaExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Abramson Cancer Center at Penn Medicine

Lead Sponsor

Trials
425
Recruited
464,000+